FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

19275611000001105: Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jul 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1762891000001117 Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1762901000001116 Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Is a Ibandronic acid 50mg tablets 28 tablet true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has AMP Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Ibandronic sodium monohydrate false Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 50mg tablets (Zentiva Pharma UK Ltd) 28 tablet 4 x 7 tablets Has specific active ingredient Ibandronate sodium monohydrate true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start